These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 30911579

  • 1. Anti-PrPC antibody rescues cognition and synapses in transgenic alzheimer mice.
    Cox TO, Gunther EC, Brody AH, Chiasseu MT, Stoner A, Smith LM, Haas LT, Hammersley J, Rees G, Dosanjh B, Groves M, Gardener M, Dobson C, Vaughan T, Chessell I, Billinton A, Strittmatter SM.
    Ann Clin Transl Neurol; 2019 Mar; 6(3):554-574. PubMed ID: 30911579
    [Abstract] [Full Text] [Related]

  • 2. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.
    Chung E, Ji Y, Sun Y, Kascsak RJ, Kascsak RB, Mehta PD, Strittmatter SM, Wisniewski T.
    BMC Neurosci; 2010 Oct 14; 11():130. PubMed ID: 20946660
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5).
    Haas LT, Kostylev MA, Strittmatter SM.
    J Biol Chem; 2014 Oct 10; 289(41):28460-77. PubMed ID: 25148681
    [Abstract] [Full Text] [Related]

  • 4. Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance.
    Smith LM, Kostylev MA, Lee S, Strittmatter SM.
    J Biol Chem; 2019 Apr 12; 294(15):6042-6053. PubMed ID: 30787106
    [Abstract] [Full Text] [Related]

  • 5. Peptide aptamer targeting Aβ-PrP-Fyn axis reduces Alzheimer's disease pathologies in 5XFAD transgenic mouse model.
    Ali T, Klein AN, Vu A, Arifin MI, Hannaoui S, Gilch S.
    Cell Mol Life Sci; 2023 May 07; 80(6):139. PubMed ID: 37149826
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Conditional Deletion of Prnp Rescues Behavioral and Synaptic Deficits after Disease Onset in Transgenic Alzheimer's Disease.
    Salazar SV, Gallardo C, Kaufman AC, Herber CS, Haas LT, Robinson S, Manson JC, Lee MK, Strittmatter SM.
    J Neurosci; 2017 Sep 20; 37(38):9207-9221. PubMed ID: 28842420
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models.
    Kostylev MA, Kaufman AC, Nygaard HB, Patel P, Haas LT, Gunther EC, Vortmeyer A, Strittmatter SM.
    J Biol Chem; 2015 Jul 10; 290(28):17415-38. PubMed ID: 26018073
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The prion protein as a receptor for amyloid-beta.
    Kessels HW, Nguyen LN, Nabavi S, Malinow R.
    Nature; 2010 Aug 12; 466(7308):E3-4; discussion E4-5. PubMed ID: 20703260
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM, King AE, Woodhouse A, Kirkcaldie MT, Vickers JC.
    Exp Neurol; 2015 May 12; 267():219-29. PubMed ID: 25747037
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The prion protein ligand, stress-inducible phosphoprotein 1, regulates amyloid-β oligomer toxicity.
    Ostapchenko VG, Beraldo FH, Mohammad AH, Xie YF, Hirata PH, Magalhaes AC, Lamour G, Li H, Maciejewski A, Belrose JC, Teixeira BL, Fahnestock M, Ferreira ST, Cashman NR, Hajj GN, Jackson MF, Choy WY, MacDonald JF, Martins VR, Prado VF, Prado MA.
    J Neurosci; 2013 Oct 16; 33(42):16552-64. PubMed ID: 24133259
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer's Disease.
    Gibbs E, Silverman JM, Zhao B, Peng X, Wang J, Wellington CL, Mackenzie IR, Plotkin SS, Kaplan JM, Cashman NR.
    Sci Rep; 2019 Jul 08; 9(1):9870. PubMed ID: 31285517
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.